T he Purpose of the Study is to evaluation of the Long-Term Safety and Effectiveness of a Drug-Coated Peripheral Balloon Dilatation Catheter in the Treatment of Femoropopliteal Artery Stenoses or Occlusive Lesions.
Aged 18 to 85 years, gender not restricted;
Rutherford grade 2 to 5
Diameter stenosis ≥70% by visual estimation or
Chronic total occlusion (CTO)
Absence of proximal inflow tract or persistent lack of proximal inflow after pretreatment
Type D or higher dissection occurring after target lesion predilation;
Residual diameter stenosis >50% following target lesion predilation;
Patients with known allergies to aspirin, clopidogrel, heparin, paclitaxel, contrast agents, etc.;